CBU
PALI icon

CIBC Bancorp USA’s Palisade Bio PALI Stock Holding History

CIBC Bancorp USA’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.2K Buy
+10,148
New +$20K ﹤0.01% 1917

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

CIBC Bancorp USA's PALI Position: Q2 2026 in Review

CIBC Bancorp USA opened a new position in Palisade Bio (PALI) in Q2 2026: 10,148 shares worth $21.2K. The stake represents ﹤0.01% of the portfolio and ranks #1917 among its holdings.

113 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • CIBC Bancorp USA held 10,148 shares of Palisade Bio worth $21.2K as of Q2 2026.
  • Palisade Bio was a new CIBC Bancorp USA position in Q2 2026.
  • Palisade Bio made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1917 holding.
  • 113 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.